• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Insufficient Information (4580)
Event Date 08/01/2022
Event Type  Injury  
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Event Description
Jada system was discontinued because they thought is wasn't working properly [device ineffective].There was bleeding around the cervical seal [device leakage].Per nurse jada system was not suctioning [device issue].I think it was a placement issue [device placement issue].Case narrative: this spontaneous report originating from united states as received from registered nurse (from a nursing staff undergoing in-service) via clinical educator, referring to a female patient of unknown age.The patient's concurrent conditions and drug reactions / allergies were not reported.The patient's medical history included pregnancy and delivery.The patient's concomitant medications included unspecified uterotonic drug.There was no maternal admission to intensive care unit (icu).This report concerned 1 patient and 1 device.On an unknown date in august 2022, the patient underwent vacuum-induced hemorrhage control system (jada system) (1.0) placement via vaginal route (lot# and expiration date were not reported for postpartum bleeding (postpartum hemorrhage).After placement, the same day of insertion at unknown time, there was a bleeding around the cervical seal (device leakage) and was disconnected and the vacuum-induced hemorrhage control system (jada system) was not suctioning according to nurse (device issue).The reporting nurse was unsure if it was inflated enough or how much fluid was used.The vacuum-induced hemorrhage control system (jada system) was discontinued (removed) as it was not working properly and did not stop control the bleeding (device ineffective), and another unspecified uterine tonic was used.The vacuum-induced hemorrhage control system (jada system) did not break (the plastic breaks apart) nor it was difficult to connect or lost connection.It was reported that the patient sought medical attention.The reporter reported that she did not think it was a quality issue and thought it was a placement issue (device placement issue).The clinical educator was unable to obtain any additional information.No additional adverse event (ae)/ product quality complaint (pqc) reported.No additional information provided.No further information provided.For vacuum-induced hemorrhage control system (jada system), the lot number and the serial number was not available.Upon internal review, device ineffective was determined to be medically significant.Medical device reporting criteria: serious injury.Fda code: (health effects - health impact per annex f): 4641 unexpected medical intervention (patient required an unforeseen medical intervention, excluding surgery, which was not on the original treatment plan).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key16064200
MDR Text Key306316905
Report Number3002806821-2022-00033
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 12/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-